Terug
Dagbereik
€ 21,37
€ 21,41
52-Weeksbereik
€ 5,64
€ 21,44
Volume
1.603.237
50D / 200D Gem.
€ 13,48
/
€ 9,02
Vorige Slotkoers
€ 21,38
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -20,6 | 0,2 |
| P/B | 5,0 | 3,0 |
| ROE % | -22,7 | 3,6 |
| Net Margin % | -67,9 | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 23,75
+11.1%
Low: € 21,50
High: € 26,00
Forward WPA
-€ 0,78
Omzet Sch.
240,45M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,85
€ 1,71 – € 2,00
|
637,33M | 2 |
| FY2029 |
€ 1,25
€ 1,15 – € 1,35
|
532,92M | 4 |
| FY2028 |
€ 0,25
-€ 0,05 – € 0,99
|
398,70M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | -€ 0,15 | -€ 0,20 | -34,3% |
| 2025-11-04 | -€ 0,28 | -€ 0,19 | +31,8% |
| 2025-08-05 | -€ 0,35 | -€ 0,29 | +17,1% |
| 2025-05-06 | -€ 0,46 | -€ 0,35 | +23,9% |
| 2025-02-25 | -€ 0,35 | -€ 0,69 | -97,1% |
| 2024-10-30 | -€ 0,41 | € 0,38 | +192,7% |
| 2024-07-30 | -€ 0,67 | -€ 0,05 | +92,5% |
| 2024-05-06 | -€ 0,67 | -€ 0,72 | -7,5% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -104,08M
Capital efficient — spends only 0,20% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)20,60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-22,74%
ROIC-21,58%
Net Margin-67,85%
Op. Margin-80,76%
Veiligheid
Debt / Equity
0,01
Current Ratio8,02
Interest Coverage0,00
Waardering
P/E Ratio
-20,57
Forward P/EN/A
P/B Ratio5,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,60% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 158,18M | Net Income (TTM) | -107,32M |
| ROE | -22,74% | ROA | -21,13% |
| Gross Margin | 89,12% | Operating Margin | -80,76% |
| Net Margin | -67,85% | Free Cash Flow (TTM) | -104,08M |
| ROIC | -21,58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 8,02 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -20,57 | Forward P/E | N/A |
| P/B Ratio | 5,00 | P/S Ratio | 13,96 |
| PEG Ratio | -4,58 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 25,02 |
| Forward P/S | 9,18 | Fwd Earnings Yield | N/A |
| FCF Yield | -4,71% | ||
| Market Cap | 2,21B | Enterprise Value | 2,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 158,18M | 131,16M | 0,0 | 0,0 | 0,0 |
| Net Income | -107,32M | -95,50M | -188,92M | -142,18M | -70,65M |
| EPS (Diluted) | -1,04 | -1,02 | -2,37 | -2,02 | -1,14 |
| Gross Profit | 140,97M | 125,88M | -383.000,0 | -531.000,0 | -199.000,0 |
| Operating Income | -127,75M | -217,27M | -206,06M | -146,91M | -72,74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 507,83M | 582,79M | 376,05M | 349,06M | 289,82M |
| Total Liabilities | 66,67M | 80,04M | 29,51M | 17,02M | 8,67M |
| Shareholders' Equity | 441,16M | 502,75M | 346,54M | 332,04M | 281,15M |
| Total Debt | 2,79M | 2,60M | 408.000,0 | 813.000,0 | 220.000,0 |
| Cash & Equivalents | 197,08M | 124,97M | 230,78M | 85,26M | 284,31M |
| Current Assets | 485,10M | 562,33M | 375,27M | 347,87M | 289,37M |
| Current Liabilities | 60,52M | 73,45M | 29,51M | 16,62M | 8,66M |